6 de diciembre de 2019
  • Jueves, 5 de Diciembre
  • 20 de diciembre de 2010

    Daiichi Sankyo Announces First European Approval for Sevikar HCT(R), a New Three-in-one Combination Product for the Trea


    Contact
    Public Relations
    Dr. Michaela Paudler-Debus
    Head of Product PR Europe
    Phone +49-89-78-08-685
    michaela.paudler-debus@daiichi-sankyo.eu
    Medical
    Joris Versteden
    Vice Director Medical and Scientific Affairs
    Phone +49-89-78-08-497
    joris.versteden@daiichi-sankyo.eu

    CONTACT: Contact: Public Relations, Dr. Michaela Paudler-Debus, Head ofProduct PR Europe, Phone +49-89-78-08-685,michaela.paudler-debus@daiichi-sankyo.eu. Medical, Joris Versteden, ViceDirector Medical and Scientific Affairs, Phone +49-89-78-08-497,joris.versteden@daiichi-sankyo.eu